Base de dados : HANSEN
Pesquisa : CELULAS CULTIVADAS [Descritor de assunto]
Referências encontradas : 24 [refinar]
Mostrando: 1 .. 20   no formato [Detalhado]

página 1 de 2 ir para página        

  1 / 24 HANSEN  
              next record last record
seleciona
para imprimir
Id:23969
Autor:Tapinos, Nikos; Ohnishi, Makoto; Rambukkana, Anura
Título:ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli
..-
Fonte:s.l; s.n; 2006. 6 p. ilus, tab, graf.
Resumo:Demyelination is a common pathologic feature in many neurodegenerative diseases including infection with leprosy-causing Mycobacterium leprae. Because of the long incubation time and highly complex disease pathogenesis, the management of nerve damage in leprosy, as in other demyelinating diseases, is extremely difficult. Therefore, an important challenge in therapeutic interventions is to identify the molecular events that occur in the early phase before the progression of the disease. Here we provide evidence that M. leprae-induced demyelination is a result of direct bacterial ligation to and activation of ErbB2 receptor tyrosine kinase (RTK) signaling without ErbB2-ErbB3 heterodimerization, a previously unknown mechanism that bypasses the neuregulin-ErbB3-mediated ErbB2 phosphorylation. MEK-dependent Erk1 and Erk2 (hereafter referred to as Erk1/2) signaling is identified as a downstream target of M. leprae-induced ErbB2 activation that mediates demyelination. Herceptin (trastuzumab), a therapeutic humanized ErbB2-specific antibody, inhibits M. leprae binding to and activation of ErbB2 and Erk1/2 in human primary Schwann cells, and the blockade of ErbB2 activity by the small molecule dual ErbB1-ErbB2 kinase inhibitor PKI-166 (ref. 11) effectively abrogates M. leprae-induced myelin damage in in vitro and in vivo models. These results may have implications for the design of ErbB2 RTK-based therapies for both leprosy nerve damage and other demyelinating neurodegenerative diseases. (AU).
Descritores:Anticorpos Monoclonais/PD
Butadienos/PD
Células COS
Células Cultivadas
Cercopithecus aethiops
Técnicas de Cocultura
Doenças Desmielinizantes/*ME/PA
Ativação Enzimática/DE
Inibidores Enzimáticos/PD
Células Hela
Hanseníase/*ME/MI
Camundongos Knockout
Proteína Quinase 1 Ativada por Mitógeno/ME
Proteína Quinase 3 Ativada por Mitógeno/ME
Mycobacterium leprae/GE/*ME
Nitrilos/PD
Pirimidinas/PD
Pirróis/PD
Receptor erbB-2/*ME
Research Support, N.I.H., Extramural
Células de Schwann/EN/ME
Nervo Ciático/ME/MI/UL
Transdução de Sinal
Limites:Ratos
Camundongos Nus
Camundongos
Humanos
Estudo Comparativo
Animais
Localização:BR191.1; 09361/s


  2 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:20767
Autor:Salem, Isam Ismail; Steffan, Gerhard; Düzgünes, Nejat
Título:Efficacy of clofazimine - modified cyclodextrin against Mycobacterium avium complex in human macrophages
..-
Fonte:s.l; s.n; 2003. 10 p. graf.
Resumo:Clofazimine, a water insoluble substituted iminophenazine derivative with anti-mycobacterial and anti-inflammatory activity, is recommended by the WHO for the treatment of leprosy. It is also active against disseminated Mycobacterium avium complex (MAC) disease in HIV-infected patients. Recently, we achieved a 4000-fold increase of clofazimine water solubility using a novel modified clofazimine-cyclodextrin complex synthesized and patented by our group [Wasserlösliche, Iminiophenazinderivate enthaltende pharmazeutische Zusammensetzungen, deren Herstellung und Verwendung, German Patent, DE19814814C2]. In this paper we examine the activity of this complex against MAC in human macrophages, and evaluate its cytotoxicity. MAC-infected macrophages were treated for 24h with free or complexed clofazimine. The in vitro minimum inhibitory concentrations of both free and complexed clofazimine were 0.1 microg/ml. Free and complexed clofazimine inhibited the growth of MAC inside macrophages to a similar extent, while modified cyclodextrin alone had no observable effects on MAC or macrophages. Complexed clofazimine was not toxic to cells at concentrations effective against MAC. The TD(50) of the modified cyclodextrin in THP-1 cell line was 297 microg/ml. (AU).
Descritores:ANTIINFECCIOSOS/quim
ANTIINFECCIOSOS/farmacol
ANTIINFECCIOSOS/tox
CELULAS CULTIVADAS
CLOFAZIMINA/quim
CLOFAZIMINA/farmacol
CLOFAZIMINA/tox
MACROFAGOS/ef drogas
TESTES DE SENSIBILIDADE MICROBIANA
COMPLEXO MYCOBACTERIUM AVIUM/ef drogas
ESTEROIS/quim
ACIDO SUCCINICO
Limites:ESTUDO COMPARATIVO
HUMANO
ANIMAL
CAMUNDONGOS
Meio Eletrônico: - .
Localização:BR191.1; 09082/s


  3 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18954
Autor:Salem, Isam Ismail; Steffan, Gerhard; Düzgünes, Nejat
Título:Efficacy of clofazimine - modified cyclodextrin against Mycobacterium avium complex in human macrophages
..-
Fonte:s.l; s.n; 2003. 10 p. graf.
Resumo:Clofazimine, a water insoluble substituted iminophenazine derivative with anti-mycobacterial and anti-inflammatory activity, is recommended by the WHO for the treatment of leprosy. It is also active against disseminated Mycobacterium avium complex (MAC) disease in HIV-infected patients. Recently, we achieved a 4000-fold increase of clofazimine water solubility using a novel modified clofazimine-cyclodextrin complex synthesized and patented by our group [Wasserlösliche, Iminiophenazinderivate enthaltende pharmazeutische Zusammensetzungen, deren Herstellung und Verwendung, German Patent, DE19814814C2]. In this paper we examine the activity of this complex against MAC in human macrophages, and evaluate its cytotoxicity. MAC-infected macrophages were treated for 24h with free or complexed clofazimine. The in vitro minimum inhibitory concentrations of both free and complexed clofazimine were 0.1 microg/ml. Free and complexed clofazimine inhibited the growth of MAC inside macrophages to a similar extent, while modified cyclodextrin alone had no observable effects on MAC or macrophages. Complexed clofazimine was not toxic to cells at concentrations effective against MAC. The TD(50) of the modified cyclodextrin in THP-1 cell line was 297 microg/ml. (AU).
Descritores:ANTIINFECCIOSOS/quim
ANTIINFECCIOSOS/farmacol
ANTIINFECCIOSOS/tox
CLOFAZIMINA/quim
CLOFAZIMINA/farmacol
CLOFAZIMINA/tox
CELULAS CULTIVADAS
MACROFAGOS/ef drogas
MACROFAGOS/microbiol
TESTES DE SENSIBILIDADE MICROBIANA
COMPLEXO MYCOBACTERIUM AVIUM/ef drogas
ESTEROIS/quim
ACIDO SUCCINICO/quim
Limites:ESTUDO COMPARATIVO
HUMANO
ANIMAL
CAMUNDONGOS
Meio Eletrônico: - .
Localização:BR191.1; 09082/s


  4 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18643
Autor:Hagge, Deanna A; Robinson, Sandra Oby; Scollard, David; McCormick, Gregory; Williams, Diana L
Título:A new model for studyng the effects of Mycobacterium leprae on Schwann cell and neuron interactions
..-
Fonte:s.l; s.n; 2002. 14 p. ilus, tab.
Resumo:Millions of patients with leprosy suffer from nerve damage resulting in disabilities as a consequence of Mycobacterium leprae infection. However, mechanisms of nerve damage have not been elucidated because of the lack of a model that maintains M. leprae viability and mimics disease conditions. A model was developed using viable M. leprae, rat Schwann cells, and Schwann cell-neuron cocultures incubated at 33 degrees C. M. leprae retained 56 per cente viability in Schwann cells for 3 weeks after infection at 33 degrees C, compared with 3.6 per cente viability at 37 degrees C. Infected Schwann cells had altered morphology and expression of genes encoding cellular adhesion molecules at 33 degrees C but were capable of interacting with and myelinating neurons. Cocultures, infected after myelination occurred, showed no morphological changes in myelin architecture after 1 month of incubation at 33 degrees C, and M. leprae retained 53 per cente viability. This article describes a new model for studying the effects of M. leprae on Schwann cells. (AU).
Descritores:CAMUNDONGOS NUS
HANSENIASE/microbiol
HANSENIASE/patol
MODELOS NEUROLOGICOS
MICROSCOPIA ELETRÔNICA DE VARREDURA
CELULAS CULTIVADAS
NEURÔNIOS/microbiol
NEURÔNIOS/patol
NEURÔNIOS/fisiol
COMUNICACAO CELULAR/fisiol
MYCOBACTERIUM LEPRAE/cresc
MYCOBACTERIUM LEPRAE/fisiol
CELULAS DE SCHWANN/microbiol
CELULAS DE SCHWANN/patol
CELULAS DE SCHWANN/fisiol
CELULAS DE SCHWANN/ultraest
Limites:HUMANO
ANIMAL
CAMUNDONGOS
RATOS
SUPPORT, NON-U.S. GOV'T
Meio Eletrônico: - .
Localização:BR191.1; 09030/s


  5 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18580
Autor:Oliveira, Rosane B; Ochoa, Maria T; Sieling, Peter A; Rea, Thomas H; Rambukkana, Anura; Sarno, Euzenir N; Modlin, Robert L
Título:Expression of toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy
..-
Fonte:s.l; s.n; 2003. 7 p. ilus, graf.
Resumo:Nerve damage is a clinical hallmark of leprosy and a major source of patient morbidity. We investigated the possibility that human Schwann cells are susceptible to cell death through the activation of Toll-like receptor 2 (TLR2), a pattern recognition receptor of the innate immune system. TLR2 was detected on the surface of human Schwann cell line ST88-14 and on cultured primary human Schwann cells. Activation of the human Schwann cell line and primary human Schwann cell cultures with a TLR2 agonist, a synthetic lipopeptide comprising the N-terminal portion of the putative Mycobacterium leprae 19-kDa lipoprotein, triggered an increase in the number of apoptotic cells. The lipopeptide-induced apoptosis of Schwann cells could be blocked by an anti-TLR2 monoclonal antibody. Schwann cells in skin lesions from leprosy patients were found to express TLR2. It was possible to identify in the lesions Schwann cells that had undergone apoptosis in vivo. The ability of M. leprae ligands to induce the apoptosis of Schwann cells through TLR2 provides a mechanism by which activation of the innate immune response contributes to nerve injury in leprosy. (AU).
Descritores:APOPTOSE
CELULAS CULTIVADAS
DANO DO DNA
IMUNIDADE NATURAL
HANSENIASE/imunol
HANSENIASE/patol
LIPOPROTEINAS/fisiol
CELULAS DE SCHWANN/patol
GLICOPROTEINAS DE MEMBRANA/anal
GLICOPROTEINAS DE MEMBRANA/fisiol
RECEPTORES DA SUPERFICIE CELULAR/anal
RECEPTORES DA SUPERFICIE CELULAR/fisiol
Limites:HUMANO
SUPPORT, NON-U.S. GOV'T
SUPPORT, U.S. GOV'T, P.H.S
Meio Eletrônico: - .
Localização:BR191.1; 09028/s


  6 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18498
Autor:Hernandez, M. O; Neves Junior, I; Sales, J. S; Carvalho, D. S; Sarno, E. N; Sampaio, E. P
Título:Induction of apoptosis in monocytes by Mycobacterium leprae in vitro: a possible role for tumour necrosis factor-alpha
..-
Fonte:s.l; s.n; 2003. 9 p. graf.
Resumo:A diverse range of infectious organisms, including mycobacteria, have been reported to induce cell death in vivo and in vitro. Although morphological features of apoptosis have been identified in leprosy lesions, it has not yet been determined whether Mycobacterium leprae modulates programmed cell death. For that purpose, peripheral blood mononuclear cells obtained from leprosy patients were stimulated with different concentrations of this pathogen. Following analysis by flow cytometry on 7AAD/CD14+ cells, it was observed that M. leprae induced apoptosis of monocyte-derived macrophages in a dose-dependent manner in both leprosy patients and healthy individuals, but still with lower efficiency as compared to M. tuberculosis. Expression of tumour necrosis factor-alpha (TNF-alpha), Bax-alpha, Bak mRNA and TNF-alpha protein was also detected in these cultures; in addition, an enhancement in the rate of apoptotic cells (and of TNF-alpha release) was noted when interferon-gamma was added to the wells. On the other hand, incubation of the cells with pentoxifylline impaired mycobacterium-induced cell death, the secretion of TNF-alpha, and gene expression in vitro. In addition, diminished bacterial entry decreased both TNF-alpha levels and the death of CD14+ cells, albeit to a different extent. When investigating leprosy reactions, an enhanced rate of spontaneous apoptosis was detected as compared to the unreactive lepromatous patients. The results demonstrated that M. leprae can lead to apoptosis of macrophages through a mechanism that could be at least partially related to the expression of pro-apoptotic members of the Bcl-2 protein family and of TNF-alpha. Moreover, while phagocytosis may be necessary, it seems not to be crucial to the induction of cell death by the mycobacteria. (AU).
Descritores:APOPTOSE/ef drogas
APOPTOSE/imunol
CELULAS CULTIVADAS
REGULACAO DA EXPRESSÃO GÊNICA
INTERFERON TIPO II/farmacol
HANSENIASE/imunol
PROTEINAS DE MEMBRANA/genet
MONOCITOS/imunol
MONOCITOS/patol
MYCOBACTERIUM LEPRAE/imunol
PENTOXIFILINA/farmacol
FAGOCITOSE/imunol
PROTEINAS PROTO-ONCOGÊNICAS/genet
FATOR DE NECROSE TUMORAL/imunol
Limites:HUMANO
MASCULINO
FEMININO
ADULTO
MEIA-IDADE
IDOSO
SUPPORT, NON-U.S. GOV'T
Meio Eletrônico: - .
Localização:BR191.1; 09128/s


  7 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:18340
Autor:Hagge, Deanna; Robinson, Sandra Oby; Scollard, David; McCormick, Gregory; Williams, Diana L
Título:A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions
..-
Fonte:s.l; s.n; 2002. 4 p. tab.
Resumo:Millions of patients with leprosy suffer from nerve damage resulting in disabilities as a consequence of Mycobacterium leprae infection. However, mechanisms of nerve damage have not been elucidated because of the lack of a model that maintains M. leprae viability and mimics disease conditions. A model was developed using viable M. leprae, rat Schwann cells, and Schwann cell-neuron cocultures incubated at 33 degrees C. M. leprae retained 56% viability in Schwann cells for 3 weeks after infection at 33 degrees C, compared with 3.6% viability at 37 degrees C. Infected Schwann cells had altered morphology and expression of genes encoding cellular adhesion molecules at 33 degrees C but were capable of interacting with and myelinating neurons. Cocultures, infected after myelination occurred, showed no morphological changes in myelin architecture after 1 month of incubation at 33 degrees C, and M. leprae retained 53% viability. This article describes a new model for studying the effects of M. leprae on Schwann cells. (AU).
Descritores:COMUNICACAO CELULAR/fisiol
CELULAS CULTIVADAS
HANSENIASE/microbiol
HANSENIASE/patol
CAMUNDONGOS NUS
MODELOS NEUROLOGICOS
NEURÔNIOS/microbiol
NEURÔNIOS/patol
NEURÔNIOS/fisiol
CELULAS DE SCHWANN/microbiol
CELULAS DE SCHWANN/patol
CELULAS DE SCHWANN/fisiol
CELULAS DE SCHWANN/ultraest
MICROSCOPIA ELETRÔNICA DE VARREDURA
MYCOBACTERIUM LEPRAE/cresc
MYCOBACTERIUM LEPRAE/fisiol
Limites:ANIMAL
HUMANO
CAMUNDONGOS
RATOS
SUPPORT, NON-U.S. GOV'T
Localização:BR191.1; 08982/s


  8 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16372
Autor:Kim, Jenny; Uyemura, Koichi; Van Dyke, Melissa K; Legaspi, Annaliza J; Rea, Thomas H; Shuai, Ke; Modlin, Robert L
Título:A role for IL-12 receptor expression and signal transduction in host defense in leprosy
..-
Fonte:s.l; s.n; 2001. 8 p. graf.
Descritores:ANTIGENOS DE BACTÉRIAS
PROTEINAS DE LIGAÇAO DE DNA
TOLERANCIA IMUNOLOGICA
IMUNIDADE CELULAR
INTERFERON TIPO II
INTERLEUCINA-12
INTERLEUCINA-12
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
TRANSFORMAÇAO LINFOCITICA
MYCOBACTERIUM LEPRAE
FOSFORILAÇAO
RECEPTORES DA INTERLEUCINA
RECEPTORES DA INTERLEUCINA
TRANSDUÇAO DE SINAL
LINFOCITOS T
TRANSATIVADORES
CELULAS CULTIVADAS
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 08631/s


  9 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16333
Autor:Brahmbhatt, S; Hussain, R; Zafar, S; Dawood, G; Ottenhoff, T. H. M; Drijfhout, J. W; Bothamley, G; Smith, S; Lopez, F. V; Dockrell, H. M
Título:Human T cell responses to peptides of the mycobacterium leprae 45-kD serine-rich antigen
..-
Fonte:s.l; s.n; 2002. 9 p. tab, graf.
Descritores:SEQUENCIA DE AMINOACIDOS
ANTIGENOS DE BACTÉRIAS
ANTIGENOS DE BACTÉRIAS
LINHAGEM CELULAR
EPITOPOS DE LINFOCITO T
EPITOPOS DE LINFOCITO T
REINO UNIDO
ANTIGENOS HLA-DR
EPITOPOS IMUNODOMINANTES
EPITOPOS IMUNODOMINANTES
INTERFERON TIPO II
HANSENIASE TUBERCULOIDE
PAQUISTAO
PEPTIDIOS
HOMOLOGIA DE SEQUENCIA DE AMINOACIDOS
SERINA
LINFOCITOS T
TUBERCULOSE PULMONAR
Células Cultivadas
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 08643/s


  10 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16325
Autor:Oliveira, Martha M; Charlab, Rosane; Pessolani, Maria Cristina V
Título:Mycobacterium bovis BCG but not mycobacterium leprae induces TNF-alpha secretion in human monocytic THP-1 cells
..-
Fonte:Rio de Janeiro; s.n; Oct. 2001. 6 p. tab, graf.
Descritores:VACINA BCG
VACINAS BACTERIANAS
BOVINOS
HANSENIASE
MONOCITOS
MONOCITOS
MYCOBACTERIUM BOVIS
MYCOBACTERIUM LEPRAE
FATOR DE NECROSE TUMORAL/BI/*SE
CELULAS CULTIVADAS
Limites:ANIMAL
Localização:BR191.1; 08634/s


  11 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:16213
Autor:Ochoa, Maria Teresa; Stenger, Steffer; Sieling, Peter A; Thoma-Uszynski, Sybille; Sabet, Shereen; Cho, Sungae; Krensky, Alan M; Rollinghoff, Martin; Sarno, Euzenir Nunes; Burdick, Anne E; Rea, Thomas H; Modlin, Robert L
Título:T-cell release of granulysin contributes to host defense in leprosy
..-
Fonte:s.l; s.n; feb. 2001. 6 p. ilus, graf.
Descritores:ANTIINFECCIOSOS
ANTIGENOS CD3
ANTIGENOS DE DIFERENCIAÇAO DE LINFOCITOS T
ANTIGENOS DE DIFERENCIAÇAO DE LINFOCITOS T
LINFOCITOS T CD4-POSITIVOS
HANSENIASE LEPROMATOSA
HANSENIASE LEPROMATOSA
HANSENIASE TUBERCULOIDE
HANSENIASE TUBERCULOIDE
Células Cultivadas
Localização:BR191.1; 08698/s


  12 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15817
Autor:Brahmbhatt, S; Hussain, R; Zafar, S; Dawood, G; Ottenhoff, Tom H. M; Drijfhout, J. W; Bothamley, G; Smith, S; Lopez, F. V; Dockrell, H. M
Título:Human T cell responses to peptides of the Mycobacterium leprae 45-KD serine-rich antigen
..-
Fonte:s.l; s.n; 2002. 9 p. tab, graf.
Descritores:SEQUENCIA DE AMINOACIDOS
ANTIGENOS DE BACTÉRIAS
ANTIGENOS DE BACTÉRIAS
LINHAGEM CELULAR
EPITOPOS DE LINFOCITO T
EPITOPOS DE LINFOCITO T
REINO UNIDO
ANTIGENOS HLA-DR
EPITOPOS IMUNODOMINANTES
EPITOPOS IMUNODOMINANTES
INTERFERON TIPO II
HANSENIASE TUBERCULOIDE
DADOS DE SEQUENCIA MOLECULAR
PESO MOLECULAR
MYCOBACTERIUM LEPRAE
PAQUISTAO
PEPTIDIOS
HOMOLOGIA DE SEQUENCIA DE AMINOACIDOS
SERINA
LINFOCITOS T
TUBERCULOSE PULMONAR
CELULAS CULTIVADAS
Limites:ESTUDO COMPARATIVO
Localização:BR191.1; 08519/s


  13 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15337
Autor:Hussain, R; Kifayet, A; Dojki, M; Dockrell, H. M
Título:Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy
..-
Fonte:s.l; s.n; 1999. 6 p. tab, graf.
Descritores:ANTICORPOS ANTI-HTLV-BLV
ANTICORPOS ANTIBACTÉRIAS
CITOCINAS
FATOR ESTIMULADOR DE COLONIAS DE GRANULOCITOS-MACROFAGOS
IGG
SWITCHING DE IMUNOGLOBULINA
INTERFERON TIPO II
MACROFAGOS
LINFOCITOS T
FATOR DE NECROSE DE TUMOR
CELULAS CULTIVADAS
Localização:BR191.1; 07258/s


  14 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:15334
Autor:Shimoji, Yoshihiro; Ng, Vincent; Matsumura, Kiichiro; Fischetti, Vincent A; Rambukkana, Anura
Título:A 21-kDa surface protein of mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion
..-
Fonte:s.l; s.n; 1999. 6 p. tab, graf.
Descritores:SEQUENCIA DE AMINOACIDOS
ADESINAS BACTERIANAS
ADESINAS BACTERIANAS
SEQUENCIA DE BASES
ELETROFORESE EM GEL DE POLIACRILAMIDA
LAMININA
HANSENIASE
CAMUNDONGOS
CAMUNDONGOS ENDOGAMICOS BALB C
MICROSCOPIA IMUNOELETRONICA
DADOS DE SEQUENCIA MOLECULAR
PESO MOLECULAR
MYCOBACTERIUM LEPRAE
SISTEMA NERVOSO PERIFÉRICO
SISTEMA NERVOSO PERIFÉRICO
CÉLULAS DE SCHWANN
PROPRIEDADES DE SUPERFICIE
CELULAS CULTIVADAS
Limites:ANIMAL
Localização:BR191.1; 07255/s


  15 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14375
Autor:Gupta, Anu; Sharma, V. K; Vohra, Harpreet; Ganguly, N. K
Título:Spontaneous apoptosis in peripheral blood mononuclear cells of leprosy patients: role of cytokines
..-
Fonte:s.l; s.n; 1999. 7 p. tab, graf.
Descritores:ANTICORPOS
ESPECIFICIDADE DE ANTICORPOS
ANTIGENOS CD28
APOPTOSE
CITOCINAS
CITOCINAS
INTERLEUCINA-1
INTERLEUCINA-6
INTERLEUCINA-6
IONOMICINA
HANSENIASE
HANSENIASE
LEUCOCITOS MONONUCLEARES
LEUCOCITOS MONONUCLEARES
ZINCO
CELULAS CULTIVADAS
FATOR DE NECROSE TUMORAL/AI/PH
Localização:BR191.1; 07501/s


  16 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14347
Autor:Misra, Namita; Selvakumar, M; Singh, S; Bharadwaj, M; Ramesh, V; Misra, R. S; Nath, Indira
Título:Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy
..-
Fonte:s.l; s.n; 1995. 6 p. tab, graf.
Descritores:ANTICORPOS
DINOPROSTONA
DINOPROSTONA
TOLERANCIA IMUNOLOGICA
INDOMETACINA
INTERLEUCINA-10
INTERLEUCINA-10
INTERLEUCINA-10
HANSENIASE LEPROMATOSA
TRANSFORMAÇAO LINFOCITICA
LINFOPENIA
MONOCITOS
MONOCITOS
CÉLULAS TH1
CÉLULAS TH1
CELULAS CULTIVADAS
Localização:BR191.1; 07196/s


  17 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14340
Autor:Mesret, Yohannes; Reed, Allen H; Howe, Rawleigh
Título:Proliferative responses of T cells from the skin and nerve lesions of leprosy patients
..-
Fonte:s.l; s.n; 1995. 10 p. tab, graf.
Descritores:ANTIGENOS CD28
ANTIGENOS CD3
ANTIGENOS CD45
INTERFERON TIPO II
RECEPTORES DA INTERLEUCINA 2
INTERLEUCINA-2
INTERLEUCINA-4
HANSENIASE
HANSENIASE
TRANSFORMAÇAO LINFOCITICA
TRANSFORMAÇAO LINFOCITICA
MITOGENOS
NERVOS PERIFÉRICOS
FITOHEMAGLUTININAS
PELE
LINFOCITOS T
LINFOCITOS T
CELULAS CULTIVADAS
Localização:BR191.1; 07189/s


  18 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14310
Autor:Stewart, G. R; Boussinesq, M; Coulson, T; Elson, L; Nutman, T; Bradley, J. E
Título:Onchocerciasis modulates the immune response to mycobacterial antigens
..-
Fonte:s.l; s.n; 1999. 7 p. graf.
Descritores:ADOLESCENCIA
ANTIGENOS DE HELMINTOS
CRIANÇA
PRÉ-ESCOLAR
INTERFERON TIPO II
INTERLEUCINA-4
HANSENIASE
HANSENIASE
LEUCOCITOS MONONUCLEARES
MYCOBACTERIUM LEPRAE
MYCOBACTERIUM TUBERCULOSIS
ONCHOCERCA VOLVULUS
ONCOCERCIASE
ONCOCERCIASE
TUBERCULINA
TUBERCULOSE
TUBERCULOSE
CELULAS CULTIVADAS
Limites:ANIMAL
Localização:BR191.1; 07413/s


  19 / 24 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14271
Autor:Singh, Neeta; Birdi, Tannaz J; Antia, Noshir H
Título:Differential in vitro modulation of schwann cell proliferation by mycobacterium leprae and macrophages in the murine strains, Swiss white and C57BI/6
..-
Fonte:s.l; s.n; 1998. 10 p. tab, graf.
Descritores:DIVISAO CELULAR
COCULTURA
HANSENIASE
MACROFAGOS
CAMUNDONGOS
CAMUNDONGOS ENDOGAMICOS C57BL
MYCOBACTERIUM LEPRAE
CÉLULAS DE SCHWANN
CÉLULAS DE SCHWANN
CÉLULAS DE SCHWANN
CELULAS CULTIVADAS
Limites:ANIMAL
Localização:BR191.1; 07165/s


  20 / 24 HANSEN  
              first record previous record
seleciona
para imprimir
Id:14124
Autor:Sreenivasan, P; Misra, P. S; Wilfred, D; Nath, I
Título:Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions
..-
Fonte:s.l; s.n; 1998. 8 p. ilus, tab.
Descritores:DOENÇA AGUDA
ELISA
ERITEMA NODOSO
INTERFERON TIPO II
INTERFERON TIPO II
INTERFERON TIPO II
INTERLEUCINA-10
INTERLEUCINA-10
INTERLEUCINA-10
INTERLEUCINA-4
INTERLEUCINA-4
INTERLEUCINA-4
HANSENIASE LEPROMATOSA
MONOCITOS
RNA MENSAGEIRO
PELE
CÉLULAS TH1
CELULAS CULTIVADAS
REACAO EM CADEIA POR POLIMERASE VIA TRANSCRIPTASE
Localização:BR191.1; 07066/s



página 1 de 2 ir para página        
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information